NCT00503451View on ClinicalTrials.gov

A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

April 30, 2010

Conditions
Non-Hodgkin LymphomaNeoplasms
Interventions
DRUG

LBH589

Trial Locations (2)

89135

Nevada Cancer Institute, Las Vegas

Unknown

Novartis Investigative Site, Rotterdam

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY